Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects
Clinical trial NCT06573528 · COMPLETED
Trial details
- NCT number
- NCT06573528
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2025-05-09
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.